Process economics evaluation of cell-free synthesis for the commercial manufacture of antibody drug conjugates. (2021)
Attributed to:
FUTURE TARGETED HEALTHCARE MANUFACTURING HUB
funded by
EPSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1002/biot.202000238
PubMed Identifier: 33231912
Publication URI: http://europepmc.org/abstract/MED/33231912
Type: Journal Article/Review
Volume: 16
Parent Publication: Biotechnology journal
Issue: 4
ISSN: 1860-6768